Logo image of CADL

CANDEL THERAPEUTICS INC (CADL) Stock Analyst Ratings

NASDAQ:CADL - Nasdaq - US1374041093 - Common Stock

7.055  +0.44 (+6.73%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to CADL. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 19.38. This target is 174.7% above the current price.
CADL was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CADL.
In the previous month the buy percentage consensus was at a similar level.
CADL was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

CADL Historical Analyst RatingsCADL Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -40 -36 -32 -28 -24 -20 -16 -12 -8 -4 0 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 7.0619.1919.3819.3819.95 - 172.01% 174.70% 174.70% 182.78%

Related screens

CADL Current Analyst RatingCADL Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2024-12-18 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-18 HC Wainwright & Co. Reiterate Buy -> Buy
2023-11-13 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-22 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-15 BMO Capital Maintains Outperform -> Outperform
2023-03-31 Credit Suisse Maintains Outperform
2022-12-07 Credit Suisse Maintains Outperform
2022-12-02 HC Wainwright & Co. Initiate Buy
2021-11-19 BMO Capital Initiate Outperform
2021-08-23 UBS Initiate Buy
2021-08-23 Credit Suisse Initiate Outperform
2021-08-23 Jefferies Initiate Buy